Patients with the polymorphism had increased risk of death due to cardiovascular causes IAM and ACV 12.1% vs. 8.0%.
Entre los pacientes con el polimorfismo hubo un aumento en el riesgo de muerte por causa cardiovascular, IAM y ACV 12,1% vs.